Johns Hopkins ABX GuideBrand Names

Etravirine (ETR)

Paul A. Pham, Pharm.D. BCPS, Alice Jenh Hsu, Pharm.D
Etravirine (ETR) is a topic covered in the Johns Hopkins ABX Guide.

To view the entire topic, please or purchase a subscription.

Official website of the Johns Hopkins Antibiotic (ABX), HIV, Diabetes, and Psychiatry Guides, powered by Unbound Medicine. Johns Hopkins Guide App for iOS, iPhone, iPad, and Android included. Explore these free sample topics:

Johns Hopkins Guides

-- The first section of this topic is shown below --

INDICATIONS

FDA

  • In combination with other ARV agents for the treatment of HIV-1 infection in treatment-experienced pts with PIs, NRTIs, and NNRTI-resistant variants.
  • Treatment-experienced HIV-infected pediatric patients (6 -18 years of age and weighing at least 16 kg).

NON-FDA APPROVED USES

  • Potential for use in first-line therapy for pts infected with NNRTI-resistant virus (untested)

-- To view the remaining sections of this topic, please or purchase a subscription --

Last updated: April 30, 2014